THE IMPACT STUDY: EXTENDING VALGANCICLOVIR PROPHYLAXIS IN KIDNEY TRANSPLANT HIGH RISK (D+/R−) RECIPIENTS IS ASSOCIATED WITH LONG-TERM BENEFITS.: 1715
2010
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI